Kanagawa, Japan

Kiyomoto Ogasawara

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyomoto Ogasawara. Retrieved from https://idiyas.com/inventor/kiyomoto-ogasawara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kiyomoto Ogasawara: Innovator in Cancer Research

Introduction

Kiyomoto Ogasawara is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of cancer research, particularly in understanding the sensitivity of cancer cells to specific inhibitors.

Latest Patents

Ogasawara holds a patent titled "Method for Predicting Sensitivity of Cancer Cell to GPX4 Inhibitor." This innovative method aims to enhance the effectiveness of cancer treatments by predicting how cancer cells respond to certain therapies.

Career Highlights

Ogasawara is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work focuses on developing advanced therapeutic strategies to combat cancer, showcasing his commitment to improving patient outcomes.

Collaborations

He collaborates with esteemed colleagues such as Hiroshi Sakamoto and Keisuke Hashimoto. Their combined expertise contributes to the advancement of cancer research and the development of innovative treatment methods.

Conclusion

Kiyomoto Ogasawara's contributions to cancer research through his patent and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…